Prama Ghosh, Amity University Kolkata After the recovery of President Donald Trump from Covid-19 using a similar therapy as of the antibody medicine from AstraZeneca Plc, the company has started its late-stage trials for the same against COVID-19. The medicine will undergo two trials on more than 60000 people starting soon. Astra has also planned […]
Prama Ghosh, Amity University Kolkata Increasing resistance to antibiotics by infectious microbes is emerging as a serious threat to mankind. To tackle this problem, nanomaterials are rapidly rising by improving the power of existing antibiotics or producing altogether new antibacterial instruments. An antibiotic works by inhibiting the synthesis of DNA, RNA or cell wall of […]
Thota Kanishka Rao, Amity University Kolkata Appendectomy has for quite some time been the standard treatment for appendicitis, even though effective utilisation of anti-microbial therapy as an option was accounted for over 60 years. Even in recent years, more than 95% of U.S. patients with appendicitis underwent an appendectomy. However, with the ongoing Covid-19 pandemic, […]
Prama Ghosh, Amity University Kolkata Past information has shown that patients with type 2 diabetes would by and large lean toward fewer injections and more prominent adaptability than is typical of the current once-daily insulin treatment. Therefore, decreasing the number of injections might build acknowledgment of and adherence to insulin treatment among patients with type […]
